Peroxisome proliferator-activated receptor ligands in atherosclerosis

By Viles-Gonzalez Juan F   Choi Brian G   Fuster Valentin   Badimon Juan J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Peroxisome Proliferator-Activated Receptor Science

By  

Current Medicinal Chemistry, Vol. 10, Iss. 4, 2003-01 ,pp. : 267-280

Bentham Science Publishers

Access to resources Recommend Favorite

Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, accelerates gastric ulcer healing in rat

By Konturek P.C.   Brzozowski T.   Kania J.   Konturek S.J.   Kwiecien S.   Pajdo R.   Hahn E.G.  

European Journal of Pharmacology, Vol. 472, Iss. 3, 2003-07 ,pp. : 213-220

Elsevier

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR)-α: A Pharmacological Target with a Promising Future

By van Raalte Daniel H.   Li Min   Pritchard P. Haydn   Wasan Kishor M.  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1531-1538

Springer Publishing Company

Access to resources Recommend Favorite

The role of peroxisome proliferator-activated receptor in bladder cancer in relation to angiogenesis and progression

By Possati L.   Rocchetti R.   Talevi S.   Beatrici V.   Margiotta C.   Ferrante L.   Calza R.   Sagrini D.   Ferri A.  

General Pharmacology, Vol. 35, Iss. 5, 2000-11 ,pp. : 269-275

Elsevier

Access to resources Recommend Favorite